Protagonist Therapeutics Inc (PTGX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | 12-2023 | 12-2022 | 12-2021 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 128,390 | 97,249 | 186,727 | 125,744 | 123,665 |
| Marketable Securities | 438,974 | 321,664 | 154,890 | 111,611 | 203,235 |
| Receivables | 121 | 165,000 | 10,000 | 10 | 1,566 |
| Other current assets | 0 | 0 | 0 | 0 | 2,792 |
| TOTAL | $577,574 | $591,641 | $355,577 | $243,077 | $340,736 |
| Non-Current Assets | |||||
| PPE Net | 3,860 | 3,190 | 1,195 | 1,565 | 1,798 |
| Investments And Advances | 78,638 | 140,252 | 0 | 0 | 0 |
| Other Non-Current Assets | 8,116 | 9,642 | 1,179 | 3,286 | 5,161 |
| TOTAL | $90,614 | $153,084 | $2,374 | $4,851 | $6,959 |
| Total Assets | $668,188 | $744,725 | $357,951 | $247,928 | $347,695 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 5,339 | 1,615 | 775 | 3,709 | 2,499 |
| Accrued Expenses | 28,269 | 23,693 | 19,358 | 24,955 | 37,716 |
| TOTAL | $45,441 | $47,398 | $21,274 | $31,179 | $44,016 |
| Non-Current Liabilities | |||||
| Deferred Revenues | 9,550 | 18,891 | N/A | N/A | 1,601 |
| Other Non-Current Liabilities | 8,040 | 10,356 | 0 | 1,141 | 3,658 |
| TOTAL | $8,040 | $22,032 | $N/A | $1,141 | $3,658 |
| Total Liabilities | $53,481 | $69,430 | $21,274 | $32,320 | $47,674 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 63,809 | 61,384 | 58,275 | 51,275 | 48,414 |
| Common Shares | 1 | 1 | 1 | N/A | N/A |
| Retained earnings | -470,671 | -340,522 | -615,710 | -536,755 | -409,362 |
| Other shareholders' equity | 641 | -82 | -105 | -359 | -299 |
| TOTAL | $614,707 | $675,295 | $336,677 | $215,608 | $300,021 |
| Total Liabilities And Equity | $668,188 | $744,725 | $357,951 | $247,928 | $347,695 |